Skip to main content
Stay up to date on PNH

Fill out the form below to stay up to date on FABHALTA and PNH.
We'll keep you informed on:

  • Important disease education

  • Patient info for treatment

  • Key data you should know

How would you describe yourself?

Please select one of the following answers below.

How would you describe yourself? *

Personal Information

Please provide the information requested below.

All fields marked with a * are required.

Contact Information

Please provide the information requested below.

Select a State
By clicking SUBMIT, you represent that you are 18 years or older and agree to the Novartis Pharmaceuticals Corporation (NPC) Terms of Use. You understand and agree that the information you provide will be used in accordance with the NPC Privacy Policy, including to provide you with marketing information, offers, and promotions, and to contact you for your opinions regarding products, programs, and services. NPC may also show you relevant health-related advertisements when you visit other websites. To learn about our interest-based ads, click hereYou understand that unless you unsubscribe, by calling 1-888-669-6682 or clicking unsubscribe in a promotional email, your consent will remain valid.


Thank you

Thank you for signing up! Be on the lookout for your welcome email and ongoing updates from us.


Important Safety Information

What is the most important information I should know about FABHALTA?

FABHALTA is a medicine that affects part of your immune system and may lower your ability to fight infections.

  • FABHALTA increases your chance of getting serious infections caused by encapsulated bacteria, including Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae type B. These serious infections may quickly become life-threatening or fatal if not recognized and treated early.
    • You must complete or update your vaccinations against these bacteria at least 2 weeks before starting FABHALTA

Approved Use

What is FABHALTA?  
FABHALTA is a prescription medicine used to treat adults with paroxysmal nocturnal hemoglobinuria (PNH).

It is not known if FABHALTA is safe and effective in children.